An OmpX mRNA-LNP vaccine induces protective humoral and cellular immunity against Klebsiella pneumoniae in a C57BL/6 mouse model
Klebsiella pneumoniae (KP) poses a significant threat to global public health, and effective preventive measures are urgently needed. The widespread antibiotic resistance of KP underscores the critical need for vaccine-based strategies. Although numerous vaccine candidates against KP have been investigated, none has yet been licensed. mRNA-LNP vaccines against KP have only recently begun to be…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
